Emerging evidence suggests that Probiotics, which are live beneficial bacteria and yeasts, may offer potential benefits for individuals with Chronic obstructive pulmonary disease (COPD). Although research in this area is still limited, several studies have indicated that Probiotics can positively impact respiratory health by reducing exacerbations and improving lung function.
One study published in the European Respiratory Journal in 2014 investigated the effects of Probiotics on patients with COPD. The researchers found that those who received probiotic supplements experienced a decrease in the frequency of exacerbations, enhanced respiratory muscle strength, and improved lung function compared to the control group. Similarly, a systematic review and meta-analysis published in the same journal in 2020 concluded that Probiotics have a significant effect in reducing the risk of COPD exacerbation.
While these findings are promising, it is important to note that more research and clinical trials are needed to fully determine the long-term benefits and mechanisms of action of Probiotics in COPD management. Additionally, the specific strains, dosages, and duration of probiotic supplementation that provide the greatest benefits for individuals with COPD are still unclear. Therefore, consulting with a healthcare professional is crucial before considering Probiotics as a part of COPD treatment.
